Home > Publications Database > In Vivo Blockade of Beta-1 and Beta-2 Integrin Activity Inhibits Splenomegaly in JAK2-V617F Positive Myeloproliferative Disease > print

001     144528
005     20230915101354.0
024 7 _ |a 10.1182/blood-2018-99-114675
|2 doi
024 7 _ |a 0006-4971
|2 ISSN
024 7 _ |a 1528-0020
|2 ISSN
037 _ _ |a DZNE-2020-00065
082 _ _ |a 610
100 1 _ |a Poschmann, Linda
|b 0
111 2 _ |a 60th American Society of Hematology Annual Meeting
|c San Diego, CA
|d 2018-12-01 - 2018-12-04
|w USA
245 _ _ |a In Vivo Blockade of Beta-1 and Beta-2 Integrin Activity Inhibits Splenomegaly in JAK2-V617F Positive Myeloproliferative Disease
260 _ _ |c 2018
264 _ 1 |3 print
|2 Crossref
|b American Society of Hematology
|c 2018-11-29
336 7 _ |a Conference Paper
|0 33
|2 EndNote
336 7 _ |a INPROCEEDINGS
|2 BibTeX
336 7 _ |a conferenceObject
|2 DRIVER
336 7 _ |a CONFERENCE_POSTER
|2 ORCID
336 7 _ |a Output Types/Conference Poster
|2 DataCite
336 7 _ |a Poster
|b poster
|m poster
|0 PUB:(DE-HGF)24
|s 1590658990_3565
|2 PUB:(DE-HGF)
|x Other
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Edelmann-Stephan, Bärbel
|b 1
700 1 _ |a Müller, Peter
|b 2
700 1 _ |a Angenstein, Frank
|0 P:(DE-2719)2810456
|b 3
|u dzne
700 1 _ |a Fischer, Thomas
|0 P:(DE-HGF)0
|b 4
773 1 8 |a 10.1182/blood-2018-99-114675
|b : American Society of Hematology, 2018-11-29
|n Supplement 1
|p 1778-1778
|3 journal-article
|2 Crossref
|t Blood
|v 132
|y 2018
|x 0006-4971
773 _ _ |a 10.1182/blood-2018-99-114675
|g Vol. 132, no. Supplement 1, p. 1778 - 1778
|p 1778-1778
|n Supplement 1
|0 PERI:(DE-600)1468538-3
|t Blood
|v 132
|y 2018
|x 0006-4971
909 C O |o oai:pub.dzne.de:144528
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2810456
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|2 G:(DE-HGF)POF3-300
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2018
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-01-11
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BLOOD : 2021
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-25
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-25
915 _ _ |a IF >= 25
|0 StatID:(DE-HGF)9925
|2 StatID
|b BLOOD : 2021
|d 2022-11-25
920 1 _ |0 I:(DE-2719)1310004
|k AG Angenstein
|l Functional Neuroimaging
|x 0
980 _ _ |a poster
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1310004
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21